<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>124</id><JournalTitle>A CLINICAL STUDY ON EPIDEMIOLOGY, PRESCRIPTION PATTERN, MONITORING AND CONTROL OF DIABETES IN SCCL MAIN HOSPITAL</JournalTitle><Abstract>The aim of the study was to identify and assess the epidemiology, prescription pattern and monitoring and
control of diabetes in SCCL Main Hospital, Kothagudem. Patient data collection form was developed based on the
essential details to be collected from the patient. Demographic information like name, age, sex, and locality were
included. A Prospective study design of 100 adult (above 18 years of age both male & female) diabetic patients were
conducted for a period of six months. The data was analyzed using Graph Pad Prism statistical software version 6.04 and
SPSS statistical package version 22. Mean and standard deviation for continuous variables and percentage for categorical
variables are reported relevant. In the study population of diabetes among males were 38% and among females were 62%.
A gradual increase in the diabetes from 41-50 years onwards, with maximum diabetes of 36% was noticed between 51-60
years of age. The mean age male were 7.6(Â±6.2 SD) and female mean age were 10.33(Â±7.7SD). Most commonly
prescribing pattern of anti diabetic drugs in monotherapy of anti-diabetic drug group was biguanide (33.33%),
sulphonylureas (19.24%) Thiozolidinediones (0.64%) Dipeptidyl Peptidase 4 Inhibitor(0.64%) and Insulin (16.66%). In
Dual therapy, 14.74% were Sulphonylurea + Biguanide and 14.74% were DPP4 + Biguanide. The over all prescribed
monotherapy percentage 70.51% and dual therapy percentage 29.48%. Average number of drugs per prescription was
18.22%. Percentage of generic names drugs 10.69% were prescribed by generic name. Percentage of antibiotic drugs
3.35% were prescribed, percentage of injections 3.35% were prescribed and Percentage of drugs prescribed from WHO
essential drugs list was 5.15%. This study depicts the use of varied normally prescribed anti-diabetic drugs. Among the
Biguanide group Metformin use was found to be maximum and Glimepiride among the sulfonylurea group. Prescribing
patterns got to be improved in accordance with WHO core indicators.</Abstract><Email>rajani.manne888@gmail.com</Email><articletype>Research</articletype><volume>9</volume><issue>1</issue><year>2019</year><keyword>Prescription pattern monitoring studies (PPMS),WHO,diabetes mellitus,medication</keyword><AUTHORS>J. Pavani,SK. Nelofer Nawaz,Ramanarayana Reddy,Rajani Gunnam,G. Nagarjuna Reddy,M. DhanaLakshmi</AUTHORS><afflication>Department of Pharmacy Practice, KLR Pharmacy College, Paloncha, Kothagudem, Telangana 507115, India,Department of Pharmacy Practice, KLR Pharmacy College, Paloncha, Kothagudem, Telangana 507115, India,Department of Pharmacy Practice, KLR Pharmacy College, Paloncha, Kothagudem, Telangana 507115, India,Department of Pharmacy Practice, KLR Pharmacy College, Paloncha, Kothagudem, Telangana 507115, India, Department of Pharmaceutical Analysis, KLR Pharmacy College, Paloncha, Kothagudem, Telangana 507115, India, Department of Pharmaceutical Analysis, KLR Pharmacy College, Paloncha, Kothagudem, Telangana 507115, India</afflication></Article></Articles>